Researchers found a genetic variant that appears to protect against the development of CHIP, a phenomenon that can lead to ...

The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.

What's a Cancer like? Just ask the friends and family in their lives — you won't find a more devoted person. As a fourth sign of the zodiac and the first water sign in the celestial lineup, Cancers ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...